NCT06752330

Brief Summary

Orthodontic patients need supplementary oral hygiene tools in addition to professional oral hygiene. The aim of this study is to evaluate the effects of Bifidobacterium animalis subs. Lactis HN019 on plaque accumulation and gingival bleeding in orthodontic patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 20, 2024

Completed
10 days until next milestone

First Posted

Study publicly available on registry

December 30, 2024

Completed
2 days until next milestone

Study Start

First participant enrolled

January 1, 2025

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2025

Completed
Last Updated

October 1, 2025

Status Verified

September 1, 2025

Enrollment Period

6 months

First QC Date

December 20, 2024

Last Update Submit

September 30, 2025

Conditions

Keywords

probioticsFixed orthodonticoral hygieneclear aligners

Outcome Measures

Primary Outcomes (1)

  • Full Mouth Bleeding Score (FMBS)

    FMBS is a dichotomous index indicating the presence of gingival bleeding on 6 surfaces, the same as FMPS, after light probing. The ratio of surfaces with bleeding to the total of the assessed surfaces is presented as a percentage.

    4 months

Secondary Outcomes (1)

  • Full Mouth Plaque Score (FMPS)

    4 months

Study Arms (2)

Domiciliary oral hygiene with probiotics

EXPERIMENTAL

During the first sitting (T0), after checking the inclusion criteria to enter the re-search protocol, a professional oral hygiene session is carried out through the use of ultrasonic inserts, hand instruments, and glycine powder. One month after the first session (T1), FMPS and FMBS are detected. Probiotic administration is discontinued in patients belonging to the test group. At 2 months from baseline (T2), plaque and bleeding indices are recalculated and, for test group patients only, probiotic supply is delivered for 1 month. Then, after 1 month (T3), plaque and bleeding indices are measured and probiotic supply is discontinued.

Dietary Supplement: Use of probiotics during oral hygiene at home

Domiciliary oral hygiene alone

NO INTERVENTION

During the first sitting (T0), after checking the inclusion criteria to enter the re-search protocol, a professional oral hygiene session is carried out through the use of ultrasonic inserts, hand instruments, and glycine powder. All patient is instructed to perform home oral hygiene procedures using a medium-bristle manual toothbrush and fluoride toothpaste (1450 ppm F) with no added anti-plaque or anti-calculus property. Patients are advised against the use of any mouthwash.

Interventions

The probiotic used in the study is Bifidobacterium Lactis HN019, distributed com-mercially in Italy by Curasept (Curasept Prevent®, Curasept S.p.A., Saronno, VA, Italy), with added Kluyveromyces Marxianus Fragilis B0399, colostrum and biotin. The probiotic was taken by patients following the manufacturer's directions via 2 chewable tablets daily, morning and evening, after normal daily oral hygiene, achieving daily average values of B. Lactis HN019 of 2\*107 CFU and Kluyveromyces marxianus fragilis B0399 of 2\*109 CFU.

Domiciliary oral hygiene with probiotics

Eligibility Criteria

Age10 Years - 30 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • age range of 10 to 30 years old;
  • good general health;
  • patients undergoing fixed multibracket orthodontic treatment;
  • patients undergoing invisible aligner orthodontic treatment.

You may not qualify if:

  • physical, mental or motor disabilities;
  • systemic conditions that influence the progression of gingivitis;
  • presence of non-plaque-induced gingivitis;
  • known allergies;
  • smokers (if more than 5 cigarettes per day);
  • use of antibiotics, anti-inflammatories, or probiotics in the 6 months prior to recruitment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

AOU Città della Salute e della Scienza

Torino, Italy, 10126, Italy

Location

MeSH Terms

Conditions

GingivitisPeriodontal Diseases

Condition Hierarchy (Ancestors)

InfectionsGingival DiseasesMouth DiseasesStomatognathic Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Masking Details
The operator performing the data collection was unaware of the group membership of the evaluated patient
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dental Hygienist

Study Record Dates

First Submitted

December 20, 2024

First Posted

December 30, 2024

Study Start

January 1, 2025

Primary Completion

June 30, 2025

Study Completion

June 30, 2025

Last Updated

October 1, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will share

IPD will shared by papers or presentations

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR

Locations